Evaluate the Pharmacokinetics and Safety of EXPAREL® Following Subcutaneous Administration in Healthy Chinese Subjects

Clinical trial NCT04158102 · COMPLETED

Trial details

NCT number: NCT04158102
Sponsor: Nuance Pharma (shanghai) Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2019-11-07
Primary completion: 2019-12-17
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.